Peter S Garcia Alx Oncology Holdings Inc (ALXO) insider trading activity

ALXO Quotes by TradingView

Peter S Garcia is CHIEF FINANCIAL OFFICER of ALX ONCOLOGY HOLDINGS INC. Currently has a direct ownership of 121,516 shares of ALXO, which is worth approximately $222,374. The most recent transaction as insider was on Aug 14, 2024, when has been sold 761 shares (Common Stock) at a price of $2.58 per share, resulting in proceeds of $1,963. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 122K
0% 3M change
40.1% 12M change
Total Value Held $222,374

PETER S GARCIA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 14 2024
SELL
Payment of exercise price or tax liability
$1,963 $2.58 p/Share
761 Reduced 0.62%
121,516 Common Stock
Jun 28 2024
SELL
Payment of exercise price or tax liability
$10,787 $6.03 p/Share
1,789 Reduced 1.44%
122,277 Common Stock
Jun 13 2024
BUY
Open market or private purchase
$102,359 $8.53 p/Share
12,000 Added 8.93%
122,348 Common Stock
Feb 14 2024
BUY
Grant, award, or other acquisition
-
25,000 Added 18.47%
110,348 Common Stock
Dec 29 2023
SELL
Open market or private sale
$28,470 $15.04 p/Share
1,893 Reduced 2.17%
85,348 Common Stock
Jul 25 2023
BUY
Grant, award, or other acquisition
-
32,000 Added 26.95%
86,738 Common Stock
Jun 30 2023
SELL
Open market or private sale
$6,510 $7.34 p/Share
887 Reduced 1.59%
54,738 Common Stock
Dec 29 2022
SELL
Open market or private sale
$9,885 $11.07 p/Share
893 Reduced 1.64%
53,723 Common Stock
Aug 05 2022
BUY
Grant, award, or other acquisition
-
29,000 Added 34.45%
55,178 Common Stock
Feb 07 2022
BUY
Exercise of conversion of derivative security
$66,750 $4.45 p/Share
15,000 Added 37.99%
24,483 Common Stock
Oct 18 2021
SELL
Open market or private sale
$410,246 $56.75 p/Share
7,229 Reduced 43.65%
9,331 Common Stock
Oct 18 2021
BUY
Exercise of conversion of derivative security
$29,494 $4.08 p/Share
7,229 Added 30.39%
16,560 Common Stock
Sep 17 2021
SELL
Open market or private sale
$901,474 $79.46 p/Share
11,345 Reduced 54.87%
9,331 Common Stock
Sep 17 2021
BUY
Exercise of conversion of derivative security
$46,288 $4.08 p/Share
11,345 Added 35.43%
20,676 Common Stock
Sep 16 2021
SELL
Open market or private sale
$114,693 $80.43 p/Share
1,426 Reduced 13.26%
9,331 Common Stock
Sep 16 2021
BUY
Exercise of conversion of derivative security
$5,818 $4.08 p/Share
1,426 Added 11.7%
10,757 Common Stock
Aug 23 2021
SELL
Open market or private sale
$4,456,200 $74.27 p/Share
60,000 Reduced 86.54%
9,331 Common Stock
Aug 23 2021
BUY
Exercise of conversion of derivative security
$244,800 $4.08 p/Share
60,000 Added 46.39%
69,331 Common Stock
Aug 17 2021
SELL
Open market or private sale
$670,300 $67.03 p/Share
10,000 Reduced 51.73%
9,331 Common Stock
Aug 17 2021
BUY
Exercise of conversion of derivative security
$40,800 $4.08 p/Share
10,000 Added 34.09%
19,331 Common Stock
Jan 28 2021
BUY
Exercise of conversion of derivative security
$25,002 $4.08 p/Share
6,128 Added 40.17%
9,128 Common Stock

Also insider at

DRRX
DURECT CORP Healthcare
PSG

Peter S Garcia

CHIEF FINANCIAL OFFICER
South San Francisco, CA

Track Institutional and Insider Activities on ALXO

Follow ALX ONCOLOGY HOLDINGS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXO shares.

Notify only if

Insider Trading

Get notified when an Alx Oncology Holdings Inc insider buys or sells ALXO shares.

Notify only if

News

Receive news related to ALX ONCOLOGY HOLDINGS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALXO